Baltimore’s Gamble on Susman Scores $670 Million in Opioid Suits (1)

December 10, 2024, 10:30 AM UTCUpdated: December 10, 2024, 10:44 PM UTC

When the city of Baltimore decided to pass on its $90 million share of nationwide opioid settlements, it instead placed a bet that an outside litigation firm could bring in more cash.

Seven years after the city began filing those cases, that bet paid off. Baltimore and its lawyers from top trial firm Susman Godfrey have racked up more than $670 million in settlements and verdicts against the companies they said were responsible for the opioid addiction crisis: McKesson, AmerisourceBergen, CVS, Walgreens, and others.

A deal with Susman gave Baltimore “significantly more resources to pursue these ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.